Vulvovaginal Candidiasis Completed Phase 2 Trials for Ibrexafungerp (DB12471)

Back to Vulvovaginal Candidiasis

Also known as: Vulvovaginal Candidiases / Vulvovaginal Candidiasis, Genital / Vulvovaginal Candidiasis (VVC) / Candidiasis, Vulvovaginal / Vulvo-vaginal Candidiasis / Acute candidiasis of vulva and vagina / Candidiasis of vulva and vagina / Candidal vulvovaginitis (disorder) / Vulvovaginal candida

Indication	Status	Phase
DBCOND0032341 (Vulvovaginal Candidiasis)	Completed	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02679456	Safety and Efficacy of Oral Ibrexafungerp (SCY-078) vs. Oral Fluconazole in Subjects With Vulvovaginal Candidiasis	Treatment	Fluconazole (DB00196) Ibrexafungerp (DB12471)